// Biotech and Pharma Therapeutics AstraZeneca Pays $185M to Add Oral GLP-1 Drug Candidate to Pipeline November 9, 2023 / AstraZeneca / GLP-1 / Metabolic Disorder The available metabolic disorder drugs targeting the GLP-1 receptor are all injectable products. The...

// Biotech and Pharma Therapeutics GSK outpaces Pfizer in RSV vaccine market November 1, 2023 / GSK / Pfizer / RSV / Vaccine  Though RSV is responsible for thousands of deaths and hospitalizations each year among young children and seniors,...